Mayo Clinic Childrens Center
Rochester, Minnesota 55905
1 studies enrolling now · 4 studies all time
What they study most
Niemann-Pick Disease, Type C, Osteogenesis Imperfecta, Wiskott-Aldrich Syndrome
Studies at this site
- Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta — Running, not enrolling
- Arimoclomol Prospective Study in Participants Diagnosed With Niemann-Pick Disease Type C — Completed
- Early Access Program With Arimoclomol in US Patients With NPC — Available (expanded access)
- Patients Treated for Wiskott-Aldrich Syndrome (WAS) Since 1990 — Completed